197 related articles for article (PubMed ID: 35049225)
1. GPR116 overexpression correlates with poor prognosis in gastric cancer.
Zheng T; Sun M; Liu L; Lan Y; Wang L; Lin F
Medicine (Baltimore); 2021 Dec; 100(48):e28059. PubMed ID: 35049225
[TBL] [Abstract][Full Text] [Related]
2. High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma.
Yang L; Lin XL; Liang W; Fu SW; Lin WF; Tian XQ; Gao YJ; Chen HY; Dai J; Ge ZZ
Oncotarget; 2017 Jul; 8(29):47943-47956. PubMed ID: 28624786
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
4. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.
Tang X; Jin R; Qu G; Wang X; Li Z; Yuan Z; Zhao C; Siwko S; Shi T; Wang P; Xiao J; Liu M; Luo J
Cancer Res; 2013 Oct; 73(20):6206-18. PubMed ID: 24008316
[TBL] [Abstract][Full Text] [Related]
5. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
6. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
9. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
11. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Tian S; Zhan N; Li R; Dong W
Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
15. Expression and clinical implication of S100A12 in gastric carcinoma.
Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
17. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
18. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
19. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]